Yang, L., Ye, F., Bao, L., Zhou, X., Wang, Z., Hu, P., . . . Bu, H. (2019). Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers. Cancer Sci.
Citación estilo ChicagoYang, Libo, et al. "Somatic Alterations of TP53, ERBB2, PIK3CA and CCND1 Are Associated With Chemosensitivity for Breast Cancers." Cancer Sci 2019.
Cita MLAYang, Libo, et al. "Somatic Alterations of TP53, ERBB2, PIK3CA and CCND1 Are Associated With Chemosensitivity for Breast Cancers." Cancer Sci 2019.
Precaución: Estas citas no son 100% exactas.